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ABSTRACT: Bisphenol A (BPA), a chemical incorporated into plastics and resins, has 13 
estrogenic activity and is associated with adverse health effects in humans and wildlife. 14 
Similarly-structured BPA analogues are widely used but far less is known about their potential 15 
toxicity or estrogenic activity in vivo. We undertook the first comprehensive analysis on the 16 
toxicity and teratogenic effects of the bisphenols BPA, BPS, BPF and BPAF in zebrafish 17 
embryo-larvae and an assessment on their estrogenic mechanisms in an estrogen-responsive 18 
transgenic fish Tg(ERE:Gal4ff)(UAS:GFP). The rank order for toxicity was 19 
BPAF>BPA>BPF>BPS. Developmental deformities for larval exposures included cardiac 20 
edema, spinal malformation and craniofacial deformities and there were distinct differences in the 21 
effects and potencies between the different bisphenol chemicals. These effects, however, 22 
occurred only at concentrations between 1.0 and 200 mg/L which exceed those in most 23 
environments. All bisphenol compounds induced estrogenic responses in 24 
Tg(ERE:Gal4ff)(UAS:GFP) zebrafish that were inhibited by co-exposure with ICI 182,780, 25 
demonstrating an estrogen receptor dependent mechanism. Target tissues included the heart, 26 
liver, somite muscle, fins and corpuscles of Stannius. The rank order for estrogenicity was 27 
BPAF>BPA=BPF>BPS. Bioconcentration factors were 4.5, 17.8, 5.3 and 0.067 for exposure 28 
concentrations of 1.0, 1.0, 0.10 and 50 mg/L for BPA, BPF, BPAF and BPS respectively. We 29 
thus show that these BPA alternatives induce similar toxic and estrogenic effects to BPA and that 30 
BPAF is more potent than BPA, further highlighting health concerns regarding the use of BPA 31 
alternatives. 32 
  33 
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INTRODUCTION 34 
Endocrine disrupting chemicals (EDCs) possess structural similarities with endogenous 35 
hormones, and/or alter hormone biosynthesis, biodegradation or excretion, and exposure to them 36 
can alter biological homeostasis, in some cases at environmentally relevant exposure 37 
concentrations. Many groups of chemicals have been identified with endocrine disrupting 38 
properties and this, together with their widespread presence in the environment, has led to health 39 
concerns for both wildlife and humans. Disruption of sexual development in wildlife is a proven 40 
exposure consequence1, and in fish exposure to environmental estrogens causes feminisation of 41 
males and alters sexual behaviour characteristics2. Estrogens, however, play much wider roles in 42 
many other developmental and homeostatic processes and therefore chemicals capable of 43 
disrupting normal estrogen signaling may have wider health effects. In humans, exposure to 44 
estrogenic chemicals has been associated with increased incidences of breast and testicular 45 
cancer, urogenital tract malformation, decrease in immune function, metabolic disease and heart 46 
disease (reviewed in Gore et al3). 47 
Bisphenol A (BPA) is a chemical used in a variety of industrial materials, particularly 48 
polycarbonate plastics and epoxy resins. Due to increasing popularity of these durable, 49 
lightweight materials, the production of BPA has steadily increased, with production exceeding 50 
2.4 million tonnes4. BPA has been described as slightly to moderately toxic to aquatic organisms5 51 
and has been identified also as an environmental estrogen. It is present in the urine of most 52 
humans6, 7 and although BPA is relatively easily conjugated and excreted, there is an almost 53 
continuous exposure for both humans and wildlife. 54 
In human epidemiological studies, BPA exposure (measured predominantly via urinary 55 
concentrations) has been linked to a variety of health symptoms including reduced sperm quality8 56 
and reduced fertilisation success9, Polycystic Ovarian Syndrome10, altered neural development 57 
11,12, obesity13, cardiovascular disease14, 15, and type 2 diabetes16. However, it should be noted that 58 
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these reported effects are statistical associations only and the findings have been treated with 59 
some caution. Many of the associated health effects are based on a spot analysis of BPA and the 60 
studies have not necessarily considered historical exposures to BPA or exposure simultaneously 61 
to other chemicals. Controlled exposures to BPA, in rodents however, have shown effects similar 62 
to those identified in human epidemiological studies, and they include developmental defects in 63 
reproductive tissues, immune system effects, and neuro-developmental effects (reviewed in 17). 64 
Some biological effects have also been reported in studies for environmentally relevant exposure 65 
doses and below the European Food Safety Authority currently recommended dose of 4 µg/kg 66 
body weight/day18. 67 
The aquatic environment is a major route for the disposal of industrial and domestic chemicals, 68 
including bisphenols, and health impacts of BPA exposure are documented for a range of aquatic 69 
animal species. The majority of studies into the effects of bisphenol exposure, have focused on 70 
fish19, 20 and effects predominantly relate to sexual development and function, and include the 71 
induction of the egg precursor protein vitellogenin, intersex (the presence of female oocytes in 72 
male gonads), inhibitory effects on sperm maturation and numbers, oocyte atresia, alterations in 73 
sex steroid level and modified behaviour. Despite the possible wide range of health effects 74 
associated with exposure to BPA proposed in mammals and fish, studies have been restricted 75 
largely to effects on sexual development/reproduction. Effects of BPA exposure on development 76 
in fish for the most part, have been reported only for concentrations far exceeding those found in 77 
most natural environments21, 22. 78 
In response to the significant data sets published supporting adverse health effects associated 79 
with BPA exposure, several authorities have taken steps to reduce human exposure. As an 80 
example, use of BPA in food contact materials has now been banned in Japan and Canada and in 81 
2011 the European Union prohibited the manufacture and import of baby bottles containing BPA.  82 
Public awareness about BPA has increased demand for BPA-free products and the manufacture 83 
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and use of alternative compounds which possess the same basic structure as BPA (the most 84 
commonly used being Bisphenol AF -BPAF, Bisphenol F -BPF and Bisphenol S -BPS).  The 85 
similarities in structure of the alterative bisphenols to BPA make them ideal as replacements for 86 
use in polymers, however these structural similarities also give cause for concern that they may 87 
also have estrogenic activity and induce similar associated health effects as BPA23. 88 
BPF, BPS and BPAF are detected in food and beverage products (in the USA) at 89 
concentrations generally below 1 ng/g24. BPS has also been detected in thermal receipt papers, 90 
currency bills and other paper products, with the highest concentration of 22 mg/g in thermal 91 
paper25. Bisphenols also occur in house dust with BPA, BPF and BPS accounting for >98% of the 92 
total bisphenol content. River and sediment samples also contain BPF and BPS, occasionally at 93 
concentrations similar to BPA26, 27. BPAF is generally found in rivers and sediments at lower 94 
concentrations than for BPA, BPF and BPS28.  95 
The toxicity of bisphenol analogues has received little attention when compared to BPA. 96 
Studies assessing BPF, BPS and BPAF for estrogenic activity in in vitro reporter systems23, 29, 30 97 
have reported varying potencies. Overall, however, findings appear to indicate BPF has a similar 98 
estrogenic potency, and BPAF greater potency, than BPA. Some in vitro studies have reported 99 
BPS being weakly active as a ligand for the estrogen receptor, but others indicate an equal 100 
potency to BPA31, 32. BPA and BPS have been reported to induce DNA damage in vitro in HepG2 101 
cells at 0.1 µM, whereas BPF and BPAF showed no such effects at 10 µM33. The mechanism(s) 102 
of action for this effect has not been established. 103 
Few studies have assessed the endocrine disrupting potential of these alternatives to BPA in 104 
vivo. In mammals, BPS, BPF and BPAF have been shown to be estrogenic in the uterotrophic 105 
assay34, 35. Other effects of BPAF observed in mammals include reductions in cholesterol, 106 
testosterone and white blood cell counts, increases in serum thyroxin values, and a disruption of 107 
the estrous cycle36, 37. In zebrafish, exposure to 0.5 µg BPS/L has been shown to impact 108 
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negatively on reproductive endpoints and gonadosomatic index38. An increase in concentrations 109 
of plasma 17β-estradiol (E2) in males and females (at concentrations of 0.5 and 50 µg/L BPS, 110 
respectively) and reduced testosterone concentrations in males (at 50 µg/L BPS) have also been 111 
reported for aqueous exposures38. Two recently published studies have also shown that BPS, 112 
BPAF and BPF induced estrogenic responses in the brain of a cyp19a1b-GFP transgenic 113 
zebrafish39, 40. These findings highlight that bisphenols marketed as safer alternatives to BPA, 114 
may similarly induce widespread and varied health effects. 115 
Here we used the zebrafish, including an estrogen-responsive transgenic fish 116 
Tg(ERE:Gal4ff)(UAS:GFP)41, to compare the toxicity, sub-lethal effects, and relative potency 117 
and target tissues for estrogenic effects of BPS, BPF and BPAF to BPA. 118 
 119 
MATERIALS AND METHODS 120 
Fish Source, Culture and Husbandry. Adult zebrafish for the provision of embryos were kept 121 
in a custom-built zebrafish aquaria facility at the University of Exeter. Effects of bisphenols on 122 
embryo development and toxicity were studied in wild-type WIK strain (originally from the Max 123 
Planck Institute, Tubingen, Germany) and the estrogenic potency and tissue targets for estrogenic 124 
responses were analysed in the transgenic zebrafish Tg(ERE:Gal4ff)(UAS:GFP)41. Fish were 125 
allowed to breed naturally and eggs were collected via collection chambers approximately 1 h 126 
post-fertilisation (hpf). Eggs were sorted to remove any unfertilised embryos prior to use. 127 
Chemical Exposures. Stock solutions of Bisphenol A (BPA, CAS 80-05-7), Bisphenol F 128 
(BPF, 620-92-8), Bisphenol S (BPS, 80-09-1) and Bisphenol AF (BPAF, 1478-61-1) (≥ 97% 129 
purity) Sigma-Aldrich Company Ltd. were prepared in ethanol in glass bottles. Stocks were 130 
further diluted in ethanol to the required concentrations prior to dilution in embryo test water. All 131 
tests were performed in reconstituted purified water in accordance with ISO guideline 7346-3. 132 
Chemicals in ethanol stock were dissolved in test water to give a final ethanol concentration of 133 
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0.01%. Solvent controls contained the equivalent ethanol concentration in ISO water. To confirm 134 
that the responses observed in Tg(ERE:Gal4ff)(UAS:GFP) exposed to the different bisphenol 135 
chemicals were mediated by an ER-dependent pathway, embryos were co-exposed with estrogen 136 
receptor antagonist ICI 182,780 (CAS, 129453-61-8)  Tocris Bioscience, Bristol, UK. ICI was 137 
dissolved in ethanol and exposed to embryos at a concentration of 607 µg/L (1 µM). 138 
Each experimental group consisted of 20 embryos exposed in 100 mL of water and was run in 139 
triplicate. Experiments were conducted in temperature controlled laboratories (28 ± 1 °C) under 140 
semi-static conditions. Exposures to determine toxic effects and morphological abnormalities 141 
were conducted from 0 hpf to 96 hpf in accordance with OECD guidelines for Fish Embryo 142 
Acute Toxicity Test (Test No. 236). Larvae were assessed on a regular basis (3, 24, 48, 72 and 96 143 
hpf) and mortality, hatching rate and abnormalities recorded. Mortality was determined based on 144 
no visible heartbeat. Morphological abnormalities were observed and photographed using an 145 
Olympus SZX16 microscope equipped with an Olympus XC10 camera. Exposures to determine 146 
estrogenic response by GFP induction assessments were conducted from 0 hpf to 120 hpf. At the 147 
end of this exposure period 120 hpf old larvae were processed for fluorescent imaging analysis.  148 
Image Analysis of Tg(ERE:Gal4ff)(UAS:GFP) Zebrafish. Tg(ERE:Gal4ff)(UAS:GFP) 149 
larvae were anesthetised with 0.4% tricane, mounted in 3% methylcellulose in ISO water and 150 
placed onto a glass-bottom 35 mm dish. All larvae were observed in lateral view and images were 151 
obtained using a Zeiss Axio Observer.Z1 equipped with an AxioCam Mrm camera (Zeiss, 152 
Cambridge, UK). All photographs were taken using the same parameters using a X10 objective. 153 
Exposure times adopted were dependent on the region photographed due to differing levels of 154 
fluorescence intensity in different target organs, (50 ms for head region, 20 ms for mid body 155 
region and 400 ms for tail section). Exposure time was kept consistent for specific regions across 156 
the fish body. Photographs were processed using the Axiovision Imaging software and 157 
fluorescence quantification was calculated using the ImageJ software (http://rsb.info.nih.gov/ij/). 158 
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For each picture intensity was measured as the mean grey value of all the pixels within a region 159 
of interest, and the region of interest was kept consistent between individuals. Background was 160 
subtracted using the ImageJ rolling ball algorithm which removes any spatial variations of the 161 
background intensities as described in Sternberg (1983)42. 162 
Determination of Chemical Concentration in Exposure Water. Measured concentrations of 163 
test chemicals were determined in triplicate from each exposure tank. Up to 100 mL of tank water 164 
was collected to which 2% methanol and 0.1% of acid acetic were added. The water samples 165 
were extracted through an Oasis HLB (6 mL, 200 mg) cartridge (Waters, Manchester, UK), 166 
previously conditioned with 5 mL of methanol and 5 mL ultrapure water at a flow rate of 5-10 167 
mL/min. Prior to the Solid Phase Extractions (SPE), two internal standard (BPA-d8 and 2,2’-168 
BPF) were added. The amount of internal standard (IS) added was calculated so that the ratio of 169 
compound/IS was 1/1. The cartridge was washed with 5 mL of distilled water, dried under 170 
vacuum, and elution was performed with 5 mL methanol. Extracts were dried, reconstituted in 171 
water/acetonitrile (7/3v/v) and passed through 0.22 µm centrifuge filters before performing LC-172 
MS. Recovery test of the SPE protocol performed at a low and high concentration for each 173 
compound (n=4 for each concentration) gave values ranging from 83 ± 2 to 108 ± 9%. See 174 
Supporting Information for full details of LC-MS analysis “Water Chemistry LC-MS 175 
Quantification”.  176 
Determination of Internal Chemical Concentration. For a series of selected exposure 177 
concentrations, 1.0 mg/L BPA, 0.10 mg/L BPAF, 1.0 mg/L BPF and 50 mg/L BPS, analyses 178 
were run to measure internal whole body concentrations. The concentrations for these analyses 179 
were selected based on the production of a strong GFP signal in several tissues in the ERE-TG 180 
zebrafish approximately comparable in intensity across treatments.  181 
Fish were exposed for 120 hpf for these uptake assessments. Five zebrafish larvae, previously 182 
anaesthetised with tricaine (0.5 g/L, non-recoverable) in 300 μL of test solution, were transferred 183 
9 
 
to a 96 well MultiScreenHTS BV Filter Plate (Merck Millipore, Ireland). The test solution was 184 
removed under vacuum and larvae were washed with culture water (containing tricaine) to 185 
eliminate residual test solution and transferred in 300 μL of pure water to a 96-well plate (Porvair 186 
Sciences, UK). Then 300 μL HPLC- grade acetonitrile was added and samples were 187 
homogenised for 3 minutes to achieve extraction of analytes. LCMS grade water (900 µL) was 188 
added to each well and after mixing the plate was centrifuged at 4000 rpm for 30 min. 189 
Supernatant solutions from each well were transferred to a 96-well plate and removed for LC-MS 190 
analysis. See Supporting Information for full details of LC-MS analysis “Internal Chemical 191 
Concentration LC-MS Quantification”. 192 
Data analysis. Concentration response curves were modelled using a generalised linear model 193 
(GLM) in R (http://www.r-project.org/) and allows for calculation of LC/EC50. For a given 194 
chemical, LC50 and EC50 were defined as the concentration inducing 50 % mortality or of the 195 
maximal effect, respectively. Abnormality occurrence is expressed as mean percentage ± 196 
standard error of the mean (SEM). Fluorescence data is expressed as mean fold induction above 197 
the solvent control ± standard error of the mean (SEM). Statistical analyses of fluorescence data 198 
were performed in IBM SPSS Statistics 23.  Statistical significance is indicated at the p < 0.05(*) 199 
or <0.01(**) level and calculated using an ANOVA and Games-Howell post hoc test. 200 
 201 
RESULTS 202 
Bisphenol Exposure Concentrations and Uptake into Embryos. Chemical analysis of 203 
working solutions confirmed bisphenol test concentrations at the start of the exposures. All 204 
bisphenols were determined to be within 10% of their nominal concentrations with the exception 205 
for exposure to 0.001 and 0.01 mg/L BPAF and 10 mg/L BPS treatments where concentration 206 
was measured to be 80, 68 and 78% of nominal respectively (Table S2). Controls did not contain 207 
bisphenols at the respective limits of detection (40 ng/L for BPA; 100 ng/L, BPF; 10 ng/L, BPAF 208 
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and 1.5 ng/L, BPS). Measured internal chemical uptake in the larvae for the different bisphenols 209 
are summarised in Table 1. Uptake of BPA was determined to be 0.31 ± 0.01 and 4.5 ± 0.4 210 
ng/larvae for fish exposures to 0.1 and 1.0 mg/L respectively, for 1000 µ/L BPF, 18 ± 1 211 
ng/larvae, for 100 µg/L BPAF, 0.53 ±0.00 ng/larvae and for 50  mg/L BPS, 3.34 ± 0.15 ng/larvae 212 
respectively. Larval volume was estimated to be 1 µL and based on these analyses, the BCF for 213 
BPA, BPF, BPAF and BPS were 4.5 ± 0.4, 17.8 ± 1.3, 5.3 ± 0.04 and 0.067 ± 0.003, respectively. 214 
Relative Toxicity of Bisphenols on Zebrafish Embryo Development. Acute toxicities of the 215 
bisphenol chemicals were observed to differ. The 96 hpf LC50 values for the different bisphenols 216 
are shown in Table 2 (full data in Figure S1) giving a rank order of BPAF>BPA>BPF>BPS from 217 
the most toxic to the least toxic. In controls mortality rates were between 0 and 10%. 218 
Embryos in control groups developed normally with a hatch rate between 85 - 100% by 72 hpf. 219 
All bisphenols were shown to delay the time of hatching with EC50 (72 hpf) values shown in 220 
Table 2 (and Figure S2). Thus, the same rank order for bisphenols occurred for hatching delay as 221 
for mortality. 222 
The incidence and type of deformity differed for different exposure concentrations and 223 
bisphenol type. Common malformations observed are shown in Figure 1 with full details in Table 224 
3. Teratogenic effects observed with exposure to BPA included cardiac edema and craniofacial 225 
abnormality, with significant effects on these endpoints observed at or above 5.0 and 10.0 mg/L 226 
respectively. Ten percent of fish were also observed to have cranial haemorrhage at an exposure 227 
of 12.5 mg/L BPA. BPF induced a range of morphological defects including cardiac edema at ≥ 228 
10 mg/L and craniofacial abnormality, spinal malformation, cranial haemorrhage and yolk sac 229 
deformity at ≥ 20 mg/L. There was also a marked decline in pigmentation in zebrafish exposed to 230 
10 mg/L BPF. The most potent bisphenol for developmental effects was BPAF, causing cardiac 231 
edema at concentrations of 1.0 mg/L. BPS caused developmental effects only at very high 232 
exposure concentrations; cardiac edema, craniofacial abnormalities and pronounced spinal 233 
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deformity were induced above 200 mg/L. No deformities were observed in any of the control 234 
groups. 235 
Estrogenic Effects of Bisphenol Chemicals Measured in ERE-TG Zebrafish Larvae. 236 
Transgenic zebrafish without chemical exposure had some detectable GFP expression in the otic 237 
vesicle (Figure 2). This fluorescence was not found to be inducible by any of the bisphenol 238 
chemicals, with a similar level of occurrence and similar intensity across all treatments. No 239 
inducible GFP expression was detected in other tissues of unexposed larvae, however very low 240 
levels of autofluorescence were present in some tissues such as the yolk sac. This did not affect 241 
quantitation of the estrogenic responses and was accounted for in background quantitation and 242 
subtraction for the individual tissues. 243 
For BPA exposure, GFP expression was first detected for exposure to 0.1 mg/L BPA where a 244 
significant increase (3.2- fold GFP induction above controls) was observed in the pericardial 245 
region (Figure 2). This was confirmed as the heart by periodic contractile movement of the 246 
expression domains. No significant GFP expression was observed in any other tissues at this 247 
exposure concentration. At the highest exposure concentration for BPA (1.0 mg/L) a strong GFP 248 
signal was observed in the heart (23.6-fold GFP induction), liver (60.4-fold GFP induction) and 249 
tail (11.2-fold GFP induction).  250 
BPAF, BPF and BPS demonstrated similar patterns of GFP expression to BPA, though 251 
concentrations necessary for comparative induction varied (Figure 2). BPF had the most similar 252 
estrogenic potency to BPA, inducing an increase in fluorescence in the heart region at both 0.1 253 
and 1.0 mg/L, with GFP inductions of 3.4-fold and 30-fold, respectively. The heart was again the 254 
only tissue expressing GFP at 0.1 mg/L BPF. At 1.0 mg/L BPF, significant GFP induction was 255 
observed in the liver and posterior tail region (124-fold and 13- fold, above controls, 256 
respectively). BPAF was the most potent estrogen of all bisphenol chemicals tested. GFP was 257 
induced in the heart (2.4-fold increase) at 0.01 mg/L BPAF increasing to a 22-fold induction in 258 
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GFP expression at 0.1 mg/L. At 0.1 mg/L, BPAF also induced GFP induction in the liver and tail 259 
region (59-fold and 7.3- fold increases above controls, respectively). BPS was relatively weak as 260 
an estrogen in ERE-TG larvae; but concentrations of 20 mg/L and 50 mg/L induced 2.7-fold and 261 
10.8-fold inductions in GFP in the heart respectively.  262 
Estrogen Receptor Inhibitor suppression of GFP expression in ERE-TG zebrafish. ICI 263 
182,780 is a high affinity nonselective estrogen receptor antagonist, devoid of any partial 264 
agonism. Co-exposure ICI 182,780 in tandem with various bisphenols was used to determine if 265 
estrogen-induced GFP expression in the ERE-TG larvae was dependent on classic estrogen 266 
receptors (ERs). Exposure to ICI 182,780 completely removed the induction of GFP expression 267 
in all tissues by all bisphenols tested (Figure 3). 268 
 269 
DISCUSSION 270 
We have provided a comprehensive assessment on BPA and its commonly used alternatives, 271 
BPF, BPAF and BPS to illustrate that all of these bisphenols can be toxic in zebrafish embryo-272 
larvae causing lethality, albeit for very high exposure concentrations (Table 2). Sub-lethal effects 273 
observed included pericardial edema, craniofacial abnormality, pigment reduction, spinal 274 
malformation and yolk sac deformity (Figure 1, Table 3). These effects occurred for lower 275 
exposure concentrations and there were distinct differences in the effects and potencies between 276 
the different bisphenol chemicals. The concentrations of the bisphenols required to induce toxic 277 
and developmental effects were, however, several orders of magnitude higher than concentrations 278 
commonly measured in the environment2, 26, 27. The highest levels of BPA reported in 279 
environmental waters are typically below 1 µg/L although concentrations up to 21 µg/L20 have 280 
been reported. For BPF, BPAF and BPS, concentrations in environmental samples, when 281 
detected, are generally below 1 ng/L but concentrations up to 19 ng/L for BPS, 246 ng/L for 282 
BPAF and 123 ng/L for BPF26, 28 have been recorded. The current trend for replacing BPA with 283 
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its structurally similar alternatives, however, will inevitably lead to increased concentrations of 284 
these chemicals in environmental and biological samples in the near future28.  285 
The 72-h EC50 values for hatching rate (5.7 mg/L) and 96-h LC50 (12 mg/L) for BPA in our 286 
study in zebrafish are similar to those determined in previous studies21, 22. Despite their similar 287 
structure, the BPA analogues had different potencies for effects on hatching rate and mortality 288 
with BPAF approximately 6-7-fold more potent than BPA. In contrast, BPS was approximately 289 
30- and 20-fold less potent than BPA for hatching rate and mortality, respectively. 290 
Similar morphological abnormalities, including cardiac edema, spinal malformation and 291 
craniofacial abnormalities, induced by the different bisphenols are consistent with those reported 292 
in the literature for BPA and may suggest similar modes of toxicity, albeit with variable 293 
potency21, 43. However, lesions were also observed that were more associated with the different 294 
bisphenol analogues. For example, lack of pigmentation for exposure to BPF at concentrations of 295 
10 mg/L and above (Figure 1). This may be due to an effect on thyroid signaling as there is 296 
evidence that BPA can bind directly to, and block, the TR44, 45. Pigmentation, however, also 297 
involves cross-talk between estrogen and thyroid signaling, complicating possible effect 298 
mechanisms44. Some pigment loss was observed in BPA exposed fish but the effect was much 299 
more pronounced for BPF exposures. Another phenotype that was more distinctive to an 300 
individual bisphenol analogue was intracranial haemorrhage for exposure to BPF (Figure 1, Table 301 
3). This may be due to a weakening of local vasculature which can arise through disruptions to 302 
thyroid and estrogen signaling21. Although BPS was the least toxic of the bisphenols tested, this 303 
analogue induced tail abnormalities not seen for other bisphenols and also induced the highest 304 
degree of pronounced curvature of the spine (Figure 1, Table 3), again suggesting differences in 305 
the mechanisms of toxicity.   306 
BPA has been shown to induce estrogen-related effects in both fish and mammals including at 307 
environmentally relevant concentrations2, 19, 20. In the ERE-TG zebrafish we found the different 308 
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bisphenol analogues induced similar target tissue response patterns to that seen for BPA and 309 
included the heart, liver, tail muscle somites and corpuscles of Stannius (Figure 2). For all 310 
bisphenols tested the most responsive tissue was the heart, though at higher concentrations the 311 
greatest response level occurred in the liver. In the heart, the bisphenol A analogues affected the 312 
atrioventricular valves and the bulbus arteriosus, as reported previously for BPA41, 46. Responses 313 
in the liver are consistent with reports of BPA, BPAF and BPS inducing the hepatic synthesis of 314 
vitellogenin in fish20, 47, 48. Responses in the muscle somites are consistent with the role of 315 
estrogen in muscle growth and for the corpuscles of Stannius in calcium handling49. As 316 
mentioned above, the brain too has been shown to be responsive to BPA and it analogues BPAF 317 
and BPF in a cyp19a1b-GFP transgenic zebrafish39.  318 
BPAF was the most potent estrogen in the ERE-TG zebrafish inducing a response in the heart 319 
at 0.01 mg/L and other tissues at 0.1 mg/L compared with threshold concentrations of between 320 
0.1 mg/L and 1.0 mg/L for BPA and BPF.  BPS was between 50- and 500-fold less potent as an 321 
estrogen than the other bisphenols. The potency order for the different bisphenols reflects that 322 
seen for their toxicity, but may operate mutually exclusive mechanisms.   323 
Several studies have shown that BPAF is around 10 times more potent than BPA as estrogen in 324 
in vitro cell systems23, 29. The reported estrogenic activities of BPF and BPS compared to BPA, 325 
however, are much more variable23, 30, 50. Data from in vitro studies can be difficult to interpret as 326 
the metabolic capabilities for most cell-based assay systems can vary according to tissue or 327 
species type40. In addition little is known about whether required co-factors for receptors are 328 
expressed in those cells, and they do not take into account the potential for bioconcentration, all 329 
of which can have a significant bearing on the biological effect of an EDC51. Few in vivo studies 330 
have investigated BPA analogues but BPS has been reported to affect egg production, plasma 331 
steroid concentration and hatching and survival rates in zebrafish from 0.01 mg/L38, 47. 332 
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BPF is a common replacement for BPA, but here we show that both chemicals share a similar 333 
level of toxicity and in vivo estrogenic potency, with other possible off-target effects not seen for 334 
BPA. BPAF is not yet used as widely as BPF or BPS in BPA-free materials but given its 335 
estrogenic and toxicity potencies we would argue that it is not an appropriate alternative to BPA. 336 
BPS, the most commonly used monomer in thermal paper and BPA-free replacement products25 337 
has been reported to share a similar potency to BPA based on in vitro studies. Our data for 338 
zebrafish would suggest that this is not the case in vivo. There is nevertheless some remaining 339 
concern over BPS because of its reported resistance to degradation and persistence in the 340 
environment52.  341 
The mechanisms of action of BPA have been relatively well studied. BPA appears to be 342 
mechanistically pleiotophic. The best established mechanism is its ability to bind to ERs and 343 
modify gene expression, albeit at effective concentrations several orders of magnitude lower than 344 
that of 17β-estradiol53, 54. Some effects may be exerted through rapid nongenomic pathways 345 
independent of classic ER signaling55, 56. BPA also has the ability to bind strongly to the estrogen 346 
related receptor ERRγ while E2 is inactive on that pathway57, 58. These ERRs can bind to EREs in 347 
ER target genes, inducing translational responses. It is therefore theoretically possible that 348 
fluorescence responses observed in ERE-TG fish resulted partly from ERR-induced promotion. 349 
Co-exposure of ERE-TG zebrafish larvae to the ER antagonist ICI 182 780 abolished the GFP 350 
expression observed in all tissues for all chemicals tested (Figure 3) strongly supporting the 351 
hypothesis that when activation of genes is induced via the ERE promoter, in these tissues, for 352 
BPA, BPF, BPAF and BPS this activation is mediated through the classical ERs. For BPS this 353 
differs from the findings of Le Fol et al 2017, who demonstrated that in the brain of cyp19a1b-354 
GFP transgenic zebrafish BPA and BPF-induced aromatase was reduced in ICI co-exposed fish 355 
but not for those exposed to BPS40. It is difficult to reconcile these differences across the different 356 
experimental models. The brain of cyp19a1b-GFP transgenic zebrafish is much more restrictive 357 
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for studies on estrogens in that only the brain fluoresces in response to estrogens in accordance 358 
with the location of the  cyp19a1b gene, thus with the exception of the brain, we cannot compare 359 
responses to BPS across comparable responding tissues in the different transgenic models. It may 360 
be the case that tissue specific factors differentially affect the interactions of the different 361 
bisphenols with the ERs in those tissues. It is also possible that BPS interacts with ERRγ to 362 
induce the observed fluorescence, though this was not confirmed. It should be recognised that the 363 
ERE-TG model only indicates presence of activity through ERE based gene activation, so cannot 364 
give evidence for nongenomic effects. Also rapid signaling effects interact with more traditional 365 
nuclear hormonal receptor pathways59. Whether these bisphenol analogues have effects on 366 
estrogen signaling, either directly or indirectly, through androgen and thyroid signaling 367 
pathways23, 50, 60, 61 also warrants investigation. 368 
It is possible that the reason, or part thereof, for differences observed between the estrogenic 369 
potency of the bisphenols is due to preferential binding to a particular estrogen receptor subtype 370 
(esr1, esr2a and/or esr2b). One in vitro study has indicated that BPA was most selective for esr1 371 
(reported as ERα) while BPS and BPF did not appear to have strong binding preference for any 372 
one estrogen receptor subtype40. In our study we found the heart was the primary tissue target for 373 
all bisphenols, followed by the liver, and given that in 5 days post fertilization zebrafish 374 
(determined via the use of whole mount in situ hybridization) esr1 transcripts predominate in the 375 
heart, esr2a (reported as esr2b) in the liver, and esr2b (reported as esr2a) is not expressed46, the 376 
preferential binding of the different bisphenols seen in vitro for the different ER subtypes would 377 
not appear to be a key factor in determining differences in bisphenol activity we observed in vivo. 378 
Potency differences between the bisphenols may also relate to differences in their 379 
bioavailability. Albeit a limited analysis, we show uptake differed between some of the bisphenol 380 
analogues (Table 1). There was an approximate 4-fold higher uptake of BPF in exposed fish 381 
compared with uptake of BPA (both with 1000 µg/L exposure). In contrast, the uptake of BPAF 382 
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resulted in a similar BCF to BPA (5.3 and 4.5 respectively). The uptake amount of BPS was 383 
similar to that for BPA, however, exposure concentrations were much higher for BPS, leading to 384 
a much lower BCF of 0.067. The similarities in the BCF of BPAF and BPA would suggest their 385 
marked differences in comparative estrogenic potency (10-fold higher for BPAF) predominantly 386 
relates to their comparative interactions with the ER(s). However, the differences in the 387 
bioavailability of BPF and BPS compared to BPA, also appears to indicate that uptake may play a 388 
key role in the response of zebrafish to these chemicals. These analyses are based on whole body 389 
burdens only and do not consider uptake into the different body tissues which could also affect 390 
their comparative potency. A previous study investigating the bioconcentration of BPS in 96 hpf 391 
zebrafish, reported a BCF of 22±3.862. The reason for the disparity between the calculated BCFs 392 
in that study and our own here is not known. One explanation, however, may relate to differences 393 
in metabolic activity in embryos at the different life periods sampled (120 hpf in this study 394 
compared with 96 hpf in62); there is rapid rate of lipid reserve utilization between 96 and 120 hpf 395 
and this may cause higher rates of metabolism of more readily biodegraded bisphenols, such as 396 
BPS. Differences between the calculated BCF between the two studies may also relate to the 397 
presence of residual BPS adsorbed to larval body surface. Thorough washing of larvae is 398 
essential prior to chemical analysis to avoid residual bisphenol bound to the body surface that 399 
will cause subsequent over estimations of BCFs.  400 
Our findings show all the bisphenols tested are toxic to fish although at concentrations that 401 
exceed those commonly measured in environmental compartments. Toxic potency and estrogenic 402 
activity varied across the bisphenols and this probably relates principally to ability of individual 403 
chemicals to bind to and activate the ERs. Differences in uptake and bioconcentration may also 404 
play a role in the varied responses observed for the different analogues. Co-treatment with an ER 405 
inhibitor indicated that estrogenic activity of BPA and all the analogues tested in our ERE-TG 406 
zebrafish was mediated by the classical ER(s) signaling pathway.  407 
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 408 
Table 1. Measured water and whole body concentrations in 120 hpf zebrafish larvae for each 409 
bisphenol. 410 
 411 
 Nominal external 
water 
concentration 
(mg/L) 
Measured 
external water 
concentration 
(mg/L) 
Measured uptake 
per larvae 
(ng/larvae) 
Estimated 
bioconcentration 
factor 
BPA   0.1   0.09 (0.01)   0.31 (0.01)   3.1 
   1.0   0.99 (0.02)   4.50 (0.42)   4.5 
BPF   1.0   1.06 (0.06) 17.8 (1.3) 17.8 
BPAF   0.1   0.09 (0.005) 0.53 (0.0035)   5.3 
BPS 50 52.3   (0.03) 3.34 (0.15)   0.067 
 412 
Data as shown are the mean of 3 replicates, each containing 5 larvae, repeated 3 times (SEM in 413 
brackets)  414 
*Larval volume was estimated to be 1 µL 415 
  416 
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Table 2. The 96 hpf mortality rate and 72 hpf hatching success rate of zebrafish larvae exposed to 417 
bisphenol chemicals (SEM in brackets) 418 
 Acute toxicity Hatching success 
 96 hpf LC50  
(mg/L) 
72 hpf EC50  
(mg/L) 
BPAF 1.6 (0.09) 0.92 (0.06) 
BPA 12 (0.22) 5.7 (0.33) 
BPF 32 (0.55) 14 (0.41) 
BPS 199 (7.6) 155 (15) 
 419 
 420 
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Table 3. Developmental abnormalities (%) observed in 96 hpf zebrafish larvae exposed to BPA, 421 
BPF, BPAF and BPS (mg/L).  422 
 
Cardiac 
edema 
Craniofacial 
abnormality 
Tail 
development 
Cranial 
haemorrhage 
Yolk sac 
deformity 
Control  - - - - - 
BPA 1.0 - - - - - 
 2.0     1.8 (1.8)     1.8 (1.8)     1.8 (1.8) - - 
 5.0   37.4 (9.0) - - - - 
 10.0 100.0    43.7 (11.7) - -     3.5 (3.5) 
 12.5 100.0  100.0  -   10.0 (10.0) - 
BPF 1.0     1.7 (1.7) - - - - 
 2.0     1.7 (1.7) -     3.3 (1.7) - - 
 5.0   10.0 (5.8)     3.3 (1.7)     1.7 (1.7)     1.7 (1.7) - 
 10.0   64.6 (7.3)     6.7 (4.4)     8.6 (3.6)     8.5 (4.4)     1.7 (1.7) 
 20.0 100.0   11.7 (7.3)   11.7 (3.3)   36.7 (4.4)   21.7 (17.0) 
 27.5   98.3 (1.7)   93.2 (3.4)   93.2 (14.0)   41.4 (0.70)   26.1 (11.0) 
 35 100.0    90.0 (8.2)   90.0 (8.2)   40.0 (33.0)   40.0 (33.0) 
BPAF 0.50     3.3 (1.7)     1.7 (1.7)     1.7 (1.7) - - 
 0.75     3.3 (3.3)     1.7 (1.7) - - - 
 1.0   15.6 (8.7) - - - - 
 2.0   34.6 (18.0)     2.8 (2.8)     2.8 (2.8) - - 
BPS 10 - - - - - 
 20     1.8 (1.8)     1.8 (1.8)     1.8 (1.8) -     1.8 (1.8) 
 50 - - - - - 
 100     3.3 (1.7)     3.3 (1.7)     1.7 (1.7) - - 
 200   94.1 (3.2)   96.3 (3.7)   82.2 (3.4)     3.7 (3.7) - 
Data as shown are the mean of 3 replicates (SEM in brackets).  – = no abnormalities observed. 423 
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 424 
 425 
 426 
Figure 1. Examples of typical teratogenic responses of zebrafish larvae observed upon exposure 427 
to bisphenol chemicals: (A) normal, (B) pigment reduction, (C) cardiac edema, (D) spinal 428 
malformation, (E) craniofacial abnormality, (F) cranial haemorrhage, (G) yolk sac malformation. 429 
 430 
  431 
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 432 
Figure 2. (A) Images of 120 hpf ERE-TG zebrafish larvae exposed to 1.0 mg/L BPA, 0.10 mg/L 433 
BPAF, 1.0 mg/L BPF and 50 mg/L BPS (images for exposures to lower concentrations not 434 
shown). Fluorescence observed in otic vesicle (ov), heart (h), liver(li), somite muscle (sm) and 435 
fin (f). Scale bar represents 200 µm; (B-D) GFP induction (fluorescence) in 120 hpf ERE-TG 436 
23 
 
zebrafish larvae exposed to bisphenol chemicals measured by fold increase above control in the 437 
(B) heart, (C) liver, (D) tail somites. Data are reported as mean ±SEM (asterisk indicate 438 
significant difference compared with the control, * p < 0.05 and ** p < 0.01.  439 
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 440 
Figure 3. (A) Images of 120 hpf ERE-TG zebrafish larvae exposed to 1.0 mg/L BPA in the 441 
presence and absence of estrogen inhibitor ICI 182 780, scale bar represents 200 µM. (B-D) GFP 442 
induction (fluorescence) in 120 hpf ERE-TG zebrafish larvae exposed to bisphenol chemicals in 443 
combination with estrogen inhibitor ICI 182 780 measured as fold increase in GFP above control 444 
in the (B) heart, (C) liver, (D) tail somites. Bisphenol concentrations were 1.0 mg/L for BPA and 445 
BPF, 0.10 mg/L for BPAF and 20 mg/L for BPS; when included ICI 182 780 concentration was 446 
607 µg/L. Data are reported as mean ±SEM (asterisk indicate significant difference compared 447 
with the control, * p < 0.05 and ** p < 0.01. 448 
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